List of Excipients in API valsartan
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing valsartan
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | DIOVAN | valsartan | 0078-0423 | CELLULOSE, MICROCRYSTALLINE | |
| Novartis Pharmaceuticals Corporation | DIOVAN | valsartan | 0078-0423 | CROSPOVIDONE | |
| Novartis Pharmaceuticals Corporation | DIOVAN | valsartan | 0078-0423 | FERRIC OXIDE YELLOW | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing valsartan
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 | CROSPOVIDONE |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 | FERRIC OXIDE RED |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 | FERRIC OXIDE YELLOW |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for valsartan
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
valsartan drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals (USA) Inc | valsartan and hydrochlorothiazide | 68382-279 |
| Zydus Lifesciences Limited | valsartan and hydrochlorothiazide | 70771-1485 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS LACTOSE
valsartan drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Medsource Pharmaceuticals | valsartan | 45865-101 |
| A-S Medication Solutions | valsartan | 50090-5190 |
| A-S Medication Solutions | valsartan | 50090-5191 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
valsartan drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Sandoz Inc | valsartan | 0781-5607 |
| Marlex Pharmaceuticals Inc | valsartan | 10135-768 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Northwind Pharmaceuticals LLC | valsartan | 51655-244 |
| ANI Pharmaceuticals Inc | valsartan | 70954-310 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
valsartan drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | valsartan | 31722-151 |
| Camber Pharmaceuticals Inc | valsartan | 31722-745 |
| AvKARE | valsartan | 42291-856 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
valsartan drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | valsartan | 31722-151 |
| Camber Pharmaceuticals Inc | valsartan | 31722-745 |
| AvKARE | valsartan | 42291-856 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
valsartan drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | valsartan and hydrochlorothiazide | 50090-6232 |
| Preferred Pharmaceuticals Inc | valsartan and hydrochlorothiazide | 68788-8463 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
valsartan drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Unit Dose Services | valsartan | 50436-2168 |
| Solco Healthcare US LLC | valsartan and hydrochlorothiazide | 43547-311 |
| Northwind Pharmaceuticals LLC | valsartan and hydrochlorothiazide | 51655-243 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
valsartan drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| AvKARE | valsartan and hydrochlorothiazide | 42291-965 |
| A-S Medication Solutions | valsartan and hydrochlorothiazide | 50090-6232 |
| Amneal Pharmaceuticals of New York LLC | valsartan and hydrochlorothiazide | 53746-845 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
valsartan drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Unit Dose Services | valsartan | 50436-2168 |
| A-S Medication Solutions | valsartan and hydrochlorothiazide | 50090-6232 |
| Northwind Pharmaceuticals LLC | valsartan and hydrochlorothiazide | 51655-243 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
valsartan drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Rebel Distributors Corp | valsartan | 21695-917 |
| Macleods Pharmaceuticals Limited | valsartan | 33342-062 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Sandoz Inc | valsartan | 0781-5607 |
| Marlex Pharmaceuticals Inc | valsartan | 10135-768 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
valsartan drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | valsartan | 21695-917 |
| Unichem Pharmaceuticals (USA) Inc | valsartan | 29300-232 |
| Aphena Pharma Solutions - Tennessee LLC | valsartan | 43353-066 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
valsartan drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | valsartan | 21695-917 |
| Macleods Pharmaceuticals Limited | valsartan | 33342-062 |
| Aphena Pharma Solutions - Tennessee LLC | valsartan | 43353-066 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
valsartan drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | valsartan and hydrochlorothiazide | 50090-2640 |
| DirectRX | valsartan and hydrochlorothiazide | 61919-634 |
| Proficient Rx LP | valsartan and hydrochlorothiazide | 63187-428 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
valsartan drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
| Company | Ingredient | NDC |
|---|---|---|
| DirectRX | valsartan and hydrochlorothiazide | 61919-634 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
valsartan drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Medsource Pharmaceuticals | valsartan | 45865-101 |
| Alembic Pharmaceuticals Limited | valsartan | 46708-044 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Sandoz Inc | valsartan | 0781-5607 |
| Marlex Pharmaceuticals Inc | valsartan | 10135-768 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
valsartan drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | valsartan | 10135-768 |
| Unichem Pharmaceuticals (USA) Inc | valsartan | 29300-232 |
| A-S Medication Solutions | valsartan | 50090-2518 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
valsartan drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Sandoz Inc | valsartan | 0781-5607 |
| Rebel Distributors Corp | valsartan | 21695-917 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Marlex Pharmaceuticals Inc | valsartan | 10135-768 |
| Unichem Pharmaceuticals (USA) Inc | valsartan | 29300-232 |
| >Company | >Ingredient | >NDC |
Excipient focus: INDIGOTINDISULFONATE SODIUM
valsartan drug variants containing INDIGOTINDISULFONATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Unit Dose Services | valsartan | 50436-2168 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing INDIGOTINDISULFONATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
valsartan drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Unichem Pharmaceuticals (USA) Inc | valsartan | 29300-232 |
| Medsource Pharmaceuticals | valsartan | 45865-114 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Sandoz Inc | valsartan | 0781-5607 |
| Marlex Pharmaceuticals Inc | valsartan | 10135-768 |
| >Company | >Ingredient | >NDC |
Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
valsartan drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | valsartan and hydrochlorothiazide | 50090-2640 |
| Proficient Rx LP | valsartan and hydrochlorothiazide | 63187-428 |
| Proficient Rx LP | valsartan and hydrochlorothiazide | 71205-004 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
valsartan drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | valsartan | 70954-310 |
| Lifsa Drugs LLC | valsartan | 72336-910 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
valsartan drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | valsartan | 31722-151 |
| Camber Pharmaceuticals Inc | valsartan | 31722-745 |
| A-S Medication Solutions | valsartan | 50090-2255 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
valsartan drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | valsartan | 70954-310 |
| Lifsa Drugs LLC | valsartan | 72336-910 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
valsartan drug variants containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Northwind Pharmaceuticals LLC | valsartan | 51655-244 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Sandoz Inc | valsartan | 0781-5607 |
| Marlex Pharmaceuticals Inc | valsartan | 10135-768 |
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
valsartan drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Northwind Pharmaceuticals LLC | valsartan | 51655-244 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Sandoz Inc | valsartan | 0781-5607 |
| Marlex Pharmaceuticals Inc | valsartan | 10135-768 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 188
valsartan drug variants containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| Medsource Pharmaceuticals | valsartan | 45865-114 |
| Alembic Pharmaceuticals Limited | valsartan | 46708-044 |
| Alembic Pharmaceuticals Inc | valsartan | 62332-044 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYDEXTROSE
valsartan drug variants containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | valsartan and hydrochlorothiazide | 0378-6321 |
| A-S Medication Solutions | valsartan and hydrochlorothiazide | 50090-5985 |
| Northwind Pharmaceuticals LLC | valsartan and hydrochlorothiazide | 51655-243 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
valsartan drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | valsartan | 31722-151 |
| Camber Pharmaceuticals Inc | valsartan | 31722-745 |
| Macleods Pharmaceuticals Limited | valsartan | 33342-062 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
valsartan drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Unichem Pharmaceuticals (USA) Inc | valsartan | 29300-232 |
| Solco Healthcare US LLC | valsartan | 43547-367 |
| A-S Medication Solutions | valsartan | 50090-2424 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
valsartan drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | valsartan | 10135-768 |
| SQUARE PHARMACEUTICALS LIMITED | valsartan | 76483-026 |
| Mylan Pharmaceuticals Inc | valsartan and hydrochlorothiazide | 0378-6321 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 4000
valsartan drug variants containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | valsartan | 10135-768 |
| Physicians Total Care Inc | valsartan | 54868-6458 |
| Dr Reddy's Laboratories Limited | valsartan | 55111-731 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
valsartan drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | valsartan | 10135-768 |
| Unichem Pharmaceuticals (USA) Inc | valsartan | 29300-232 |
| Camber Pharmaceuticals Inc | valsartan | 31722-151 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOLS
valsartan drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Aphena Pharma Solutions - Tennessee LLC | valsartan | 43353-203 |
| Northwind Pharmaceuticals | valsartan | 51655-751 |
| Sandoz Inc | valsartan and hydrochlorothiazide | 0781-5948 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
valsartan drug variants containing POLYVINYL ALCOHOL
valsartan drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM SORBATE
valsartan drug variants containing POTASSIUM SORBATE
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | valsartan | 70954-310 |
| Lifsa Drugs LLC | valsartan | 72336-910 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing POTASSIUM SORBATE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
valsartan drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | valsartan | 31722-151 |
| Camber Pharmaceuticals Inc | valsartan | 31722-745 |
| A-S Medication Solutions | valsartan | 50090-2255 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
valsartan drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Unichem Pharmaceuticals (USA) Inc | valsartan | 29300-232 |
| Unit Dose Services | valsartan | 50436-2168 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Sandoz Inc | valsartan | 0781-5607 |
| Marlex Pharmaceuticals Inc | valsartan | 10135-768 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
valsartan drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | valsartan | 70954-310 |
| Lifsa Drugs LLC | valsartan | 72336-910 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
valsartan drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | valsartan | 31722-151 |
| Camber Pharmaceuticals Inc | valsartan | 31722-745 |
| A-S Medication Solutions | valsartan | 50090-2255 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
valsartan drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | valsartan | 70954-310 |
| Lifsa Drugs LLC | valsartan | 72336-910 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
valsartan drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Unichem Pharmaceuticals (USA) Inc | valsartan | 29300-232 |
| A-S Medication Solutions | valsartan | 50090-2518 |
| ScieGen Pharmaceuticals INC | valsartan | 50228-135 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
valsartan drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Aphena Pharma Solutions - Tennessee LLC | valsartan | 43353-203 |
| Medsource Pharmaceuticals | valsartan | 45865-114 |
| Alembic Pharmaceuticals Limited | valsartan | 46708-044 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, PREGELATINIZED CORN
valsartan drug variants containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| LUPIN LIMITED | valsartan and hydrochlorothiazide | 57297-103 |
| Dispensing Solutions Inc | valsartan and hydrochlorothiazide | 68258-6969 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
valsartan drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | valsartan | 70954-310 |
| Lifsa Drugs LLC | valsartan | 72336-910 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
valsartan drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Unichem Pharmaceuticals (USA) Inc | valsartan | 29300-232 |
| Macleods Pharmaceuticals Limited | valsartan | 33342-062 |
| AvKARE | valsartan | 42291-856 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
valsartan drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | valsartan | 70954-310 |
| Lifsa Drugs LLC | valsartan | 72336-910 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
valsartan drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | valsartan and hydrochlorothiazide | 0378-6321 |
| A-S Medication Solutions | valsartan and hydrochlorothiazide | 50090-5985 |
| Northwind Pharmaceuticals LLC | valsartan and hydrochlorothiazide | 51655-243 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
valsartan drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | valsartan | 70954-310 |
| Lifsa Drugs LLC | valsartan | 72336-910 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Excipient focus: VANILLIN
valsartan drug variants containing VANILLIN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Mylan Pharmaceuticals Inc | valsartan and hydrochlorothiazide | 0378-6321 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing VANILLIN
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Sandoz Inc | valsartan | 0781-5607 |
| Marlex Pharmaceuticals Inc | valsartan | 10135-768 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
valsartan drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | valsartan | 70954-310 |
| Lifsa Drugs LLC | valsartan | 72336-910 |
| >Company | >Ingredient | >NDC |
valsartan drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | valsartan | 0078-0423 |
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Sandoz Inc | valsartan | 0781-5607 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
